pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›ofatumumab
drug
save

ofatumumab

updated 3mo ago
by Henan Provincial People's Hospital
community read0 votes

🐶 often sniffed alongside

top 3
  • drugKESIMPTA27 co-mentions · 14 sources
  • tagApproval26 co-mentions · 13 sources
  • companyHenan Provincial People's Hospital1 co-mentions · 1 sources

all catalysts(1)

phase 1 2 completion · 1
Apr 30, 2026
phase 1 2 completion
4mo ago
Henan Provincial People's Hospital — ofatumumab (Phase I/II Trial Completion)
ofatumumab
→

Trials studying ofatumumab

  • —A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosisrecruitingn=800
  • —Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking Ofatumumabenrolling by invitationn=75
  • —A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babiesactive not recruitingn=1,178
  • —Assessment of the Quality of Life of Multiple Sclerosis Patients Treated With Ofatumumab in Real-life in Franceactive not recruitingn=302
  • phase3Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumabactive not recruitingn=196
  • —Kesimpta® (Ofatumumab) in Swiss Multiple Sclerosis Patients - an Observational Studycompletedn=107
  • —ITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS Patientsactive not recruitingn=379
  • phase3An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumabcompletedn=562
more trials →

News(0)

no news has mentioned this drug yet

Data sources
ClinicalTrials.gov
last refreshed 6m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?